I
Inga Zerr
Researcher at German Center for Neurodegenerative Diseases
Publications - 408
Citations - 17848
Inga Zerr is an academic researcher from German Center for Neurodegenerative Diseases. The author has contributed to research in topics: Dementia & PRNP. The author has an hindex of 61, co-authored 370 publications receiving 15350 citations. Previous affiliations of Inga Zerr include University of Göttingen.
Papers
More filters
Journal ArticleDOI
Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects
Piero Parchi,Armin Giese,Sabina Capellari,Paul Brown,Walter J. Schulz-Schaeffer,Otto Windl,Inga Zerr,Herbert Budka,Nicolas Kopp,Pedro Piccardo,Sigrid Poser,Amyn M. Rojiani,Nathalie Streichemberger,Jean Julien,Claude Vital,Bernardino Ghetti,Pierluigi Gambetti,Hans A. Kretzschmar +17 more
TL;DR: The present data demonstrate the existence of six phenotypic variants of sCJD, and the physicochemical properties of PrPSc in conjunction with the PRNP codon 129 genotype largely determine this phenotypesic variability, and allow a molecular classification of the disease variants.
Journal ArticleDOI
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
Inga Zerr,Kai Kallenberg,David Summers,C. Romero,Ana Lia Taratuto,Uta Heinemann,Maren Breithaupt,Daniela Varges,Bettina Meissner,Anna Ladogana,Maaike Schuur,Stéphane Haïk,Steven J. Collins,Gerard H. Jansen,G. B. Stokin,José Pimentel,Ekkehard Hewer,D. Collie,Pete Smith,H. Roberts,Jean-Philippe Brandel,C M van Duijn,Maurizio Pocchiari,C. Begue,Patrick Cras,Robert G. Will,Pascual Sánchez-Juan +26 more
TL;DR: Cerebral cortical signal increase and high signal in caudate nucleus and putamen on fluid attenuated inversion recovery or diffusion-weight imaging magnetic resonance imaging are useful in the diagnosis of sporadic Creutzfeldt–Jakob disease.
Journal ArticleDOI
Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.
Inga Zerr,Maurizio Pocchiari,Steven J. Collins,J.-P. Brandel,J de Pedro Cuesta,Richard Knight,H. Bernheimer,Franco Cardone,N. Delasnerie-Laupretre,N. Cuadrado Corrales,Anna Ladogana,Monika Bodemer,Ashley Fletcher,T. Awan,A. Ruiz Bremón,Herbert Budka,Jean-Louis Laplanche,Robert G. Will,Sigrid Poser +18 more
TL;DR: In this paper, a comparison of clinical and neuropathologic diagnoses and evaluation of the sensitivity and specificity of EEG and 14-3-3 CSF immunoassay were conducted.
Journal ArticleDOI
Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease
Inga Zerr,Monika Bodemer,Olaf Gefeller,Markus Otto,Sigrid Poser,Jens Wiltfang,Otto Windl,Hans A. Kretzschmar,Thomas Weber +8 more
TL;DR: CSF analysis for 14‐3‐3 protein should thus be performed in any case suspect for CJD, as false‐positive results in a single CSF analysis were seen in patients with herpes simplex encephalitis, hypoxic brain damage, atypical enphalitis, intracerebral metastases of a bronchial carcinoma, metabolic encephalopathy, and progressive dementia of unknown cause.
Journal ArticleDOI
Genetic prion disease: the EUROCJD experience.
Gabor G. Kovacs,Maria Puopolo,Anna Ladogana,Maurizio Pocchiari,Herbert Budka,Cornelia M. van Duijn,Steven J. Collins,Alison Boyd,Antonio Giulivi,Mike Coulthart,N. Delasnerie-Laupretre,Jean Philippe Brandel,Inga Zerr,Hans A. Kretzschmar,Jesús de Pedro-Cuesta,Miguel Calero-Lara,Markus Glatzel,Adriano Aguzzi,Matthew Bishop,Richard Knight,Girma Belay,Robert G. Will,Eva Mitrova +22 more
TL;DR: The authors' results show that clinicopathological phenotypes include genetic Creutzfeldt–Jakob disease (gCJD), fatal familial insomnia (FFI), and Gerstmann–Sträussler–Scheinker disease (GSS).